[Inhibition of histamine release from human basophils by glucocorticoids]. 1988

A Watanabe, and C Urata, and Y Abe, and Y Ogawa, and H Nomoto, and N Takei, and M Mizobe, and K Mano

UI MeSH Term Description Entries
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006636 Histamine Release The secretion of histamine from mast cell and basophil granules by exocytosis. This can be initiated by a number of factors, all of which involve binding of IgE, cross-linked by antigen, to the mast cell or basophil's Fc receptors. Once released, histamine binds to a number of different target cell receptors and exerts a wide variety of effects. Histamine Liberation,Histamine Liberations,Histamine Releases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D001491 Basophils Granular leukocytes characterized by a relatively pale-staining, lobate nucleus and cytoplasm containing coarse dark-staining granules of variable size and stainable by basic dyes. Basophil
D001623 Betamethasone A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724) Betadexamethasone,Flubenisolone,Celeston,Celestona,Celestone,Cellestoderm

Related Publications

A Watanabe, and C Urata, and Y Abe, and Y Ogawa, and H Nomoto, and N Takei, and M Mizobe, and K Mano
June 1989, Biochemical pharmacology,
A Watanabe, and C Urata, and Y Abe, and Y Ogawa, and H Nomoto, and N Takei, and M Mizobe, and K Mano
September 1983, Clinical immunology and immunopathology,
A Watanabe, and C Urata, and Y Abe, and Y Ogawa, and H Nomoto, and N Takei, and M Mizobe, and K Mano
May 1967, Blood,
A Watanabe, and C Urata, and Y Abe, and Y Ogawa, and H Nomoto, and N Takei, and M Mizobe, and K Mano
July 1985, Agents and actions,
A Watanabe, and C Urata, and Y Abe, and Y Ogawa, and H Nomoto, and N Takei, and M Mizobe, and K Mano
January 1984, International archives of allergy and applied immunology,
A Watanabe, and C Urata, and Y Abe, and Y Ogawa, and H Nomoto, and N Takei, and M Mizobe, and K Mano
April 1988, Agents and actions,
A Watanabe, and C Urata, and Y Abe, and Y Ogawa, and H Nomoto, and N Takei, and M Mizobe, and K Mano
June 1981, The Journal of clinical investigation,
A Watanabe, and C Urata, and Y Abe, and Y Ogawa, and H Nomoto, and N Takei, and M Mizobe, and K Mano
September 1997, International archives of allergy and immunology,
A Watanabe, and C Urata, and Y Abe, and Y Ogawa, and H Nomoto, and N Takei, and M Mizobe, and K Mano
October 1983, The Journal of clinical investigation,
A Watanabe, and C Urata, and Y Abe, and Y Ogawa, and H Nomoto, and N Takei, and M Mizobe, and K Mano
August 1984, Arerugi = [Allergy],
Copied contents to your clipboard!